Pre-earnings options volume in TransMedics (TMDX) Group is 2.0x normal with calls leading puts 9:4. Implied volatility suggests the market is anticipating a move near 14.5%, or $13.81, after results are released. Median move over the past eight quarters is 11.6%.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMDX:
- TransMedics price target raised to $105 from $90 at Piper Sandler
- TransMedics Group’s OCS Drives Structural Transformation in Liver Transplantation with Increased DCD Liver Utilization
- TransMedics Group: Strong Buy Rating Amidst Robust DCD Market Performance and Growth Prospects
- TransMedics Group: Strong Market Position and Growth Potential Justify Buy Rating